Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 10 of 103 > >>
EC Number Inhibitors Commentary Structure
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.341-benzyl-1H-pyrazole-4-carboxylic acid 4-carbamimidoyl-benzylamide ASP-440, small molecule inhibitor of plasma kallikrein Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.342-mercaptoethanol inhibition of prekallikrein activation Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.342-[3'-acetyl-5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-6-hydroxybiphenyl-3-yl]butanedioic acid - Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.342-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-2',6-dihydroxybiphenyl-3-yl]butanedioic acid - Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.342-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-2'-fluoro-6-hydroxybiphenyl-3-yl]butanedioic acid - Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.342-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-3',6-dihydroxybiphenyl-3-yl]butanedioic acid - Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.342-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-3'-carbamoyl-6-hydroxybiphenyl-3-yl]butanedioic acid inhibitor with the best potency and selectivity profile for plasma kallikrein versus related serine proteases. This compound is highly stable in vivo and could be further developed for the treatment and inflammatory or coagulation disorders. Pharmacokinetic data Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.342-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-3'-chloro-6-hydroxybiphenyl-3-yl]butanedioic acid - Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.342-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-3'-cyano-6-hydroxybiphenyl-3-yl]butanedioic acid - Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.342-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-4'-chloro-6-hydroxybiphenyl-3-yl]butanedioic acid - Go to the Ligand Summary Page
Results 1 - 10 of 103 > >>